Increased pro-inflammatory cytokine production in down syndrome children upon stimulation with live influenza a virus

Journal of Clinical Immunology

Volumn 32, Issue 2, 2012, Pages 323-329

  Broers, Chantal J M ^a   Gemke, Reinoud J B J ^a   Weijerman, Michel E ^a   Van Der Sluijs, Koen F ^b   Van Furth, A Marceline ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Children; Cytokines; Down syndrome; Influenza Avirus; Viral infection

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; VIRUS RNA; AUTACOID; CYTOKINE;

ARTICLE; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMETRY; DISEASE COURSE; DISEASE SEVERITY; DOWN SYNDROME; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE RESPONSE; INFLUENZA A; INFLUENZA VIRUS A; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD; VIRAL CLEARANCE; VIRUS LOAD; ADOLESCENT; BLOOD; IMMUNOLOGY; INFLUENZA; PRESCHOOL CHILD; VIROLOGY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CYTOKINES; DOWN SYNDROME; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MALE; VIRAL LOAD;

EID: 84863568773     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-011-9625-4     Document Type: Article

References (38)

1. Weijerman ME, van Furth AM, Vonk Noordegraaf A, van Wouwe JP, Broers CJM, Gemke RJBJ. Prevalence, neonatal characteristics, and first-year mortality of Down syndrome: a national study. J Pediatr. 2008;152:15-9. (Pubitemid 350265948)
2. Shin M, Besser LM, Kucik JE, Lu C, Siffel C, Correa A, et al. Prevalence of Down syndrome among children and adolescents in 10 regions of the United States. Pediatrics. 2009;124:1565-71.
3. Weijerman ME, de Winter JP. Clinical practice. The care of children with Down syndrome. Eur J Pediatr. 2010;169(12):1445-52.
4. Roizen NJ, Patterson D. Down's syndrome. Lancet. 2003;361:1281-89. (Pubitemid 36428586)
5. Hilton JM, Fitzgerald DA, Cooper DM. Respiratory morbidity of hospitalized children with trisomy 21. J Paediatr Child Health. 1999;35:383-6. (Pubitemid 29374428)
6. van Trotsenburg AS, Heymans HS, Tijssen JG, de Vijlder JJ, Vulsma T. Comorbidity, hospitalization, and medication use and their influence on mental and motor development of young infants with Down syndrome. Pediatrics. 2006;118:1633-9. (Pubitemid 46393811)
7. Bloemers BLP, van Furth AM, Weijerman ME, Gemke RJBJ, Broers CJM, van den Ende K, et al. Down syndrome: a novel risk factor for respiratory syncytial virus bronchiolitis. A prospective birth-cohort study. Pediatrics. 2007;120:e1076-81. (Pubitemid 47549555)
8. Kristensen K, Stensballe LG, Bjerre J, Roth D, Fisker N, Kongstad T, et al. Risk factors for respiratory syncytial virus hospitalisation in children with heart disease. Arch Dis Child. 2009;94:785-9.
9. Medrano López C, García-Guereta Silva L, Lirio Caero J, Garcia Perez J, et al. [Respiratory infections, Down's syndrome and congenital heart disease: the CIVIC 21 study]. An Pediatr (Barc). 2009;71:38-46.
10. Megged O, Schlesinger Y. Down syndrome and respiratory syncytial virus infection. Pediatr Infect Dis J. 2010;29:672-3.
11. Pérez-Padilla R, Fernández R, García-Sancho C, Franco-Marina F, Aburto O, Lopez-Gatell H, et al. Pandemic (H1N1) 2009 virus and Down syndrome patients. Emerg Infect Dis. 2010;16:1312-4.
12. Frazier JB, Friedman B. Swallow function in children with Down syndrome: a retrospective study. Dev Med Child Neurol. 1996;38:695-703. (Pubitemid 26252566)
13. Shott SR. Down Syndrome: Common Otolaryngologic Manifestations. Am J Med Genet Part C Semin Med Genet. 2006;142C:131-40. (Pubitemid 44298195)
14. McDowell KM, Craven DI. Pulmonary complications of Down syndrome during childhood. J Pediatr. 2010. doi:10.1016/j.jpeds.2010.07.023.
15. Bloemers BLP, Broers CJM, Bont L, Weijerman ME, Gemke RJBJ, van Furth AM. Increased risk of respiratory tract infections in children with Down syndrome: the consequence of an altered immune system. Microbes Infect. 2010;12:799-808.
16. Nisihara RM, Utiyama SRR, Oliveira NP, Messias-Reason IJ. Mannan-binding lectin deficiency increases the risk of recurrent infections in children with Down's syndrome. Hum Immunol. 2010;71:63-6.
17. Bloemers BLP, van Bleek GM, Kimpen JLL, Bont L. Distinct abnormalities in the innate immune system of children with Down syndrome. J Pediatr. 2010;156:804-9.
18. De Hingh YCM, van der Vossen PW, Gemen EFA, Mulder AB, Hop WCJ, Brus F, et al. Intrinsic abnormalities of lymphocyte counts in children with Down syndrome. J Pediatr. 2005;147:744-7. (Pubitemid 41774828)
19. Kusters MAA, Verstegen RHJ, Gemen EFA, de Vries E. Intrinsic defect of the immune system in children with Down syndrome: a review. Clin Exp Immunol. 2009;156:189-93.
20. Cossarizza A, Monti D, Montagnani G, Ortolani C, Masi M, Zannotti M, et al. Precocious aging of the immune system in Down syndrome: alteration of B lymphocytes, T-lymphocyte subsets, and cells with natural killer markers. Am J Med Genet Suppl. 1990;7:213-8.
21. Guazzarotti L, Trabattoni D, Castelletti E, Boldrighini B, Piacentini L, Duca P, et al. T lymphocyte maturation is impaired in healthy young individuals carrying trisomy 21 (Down syndrome). Am J Intellect Dev Disabil. 2009;114:100-9.
22. Kusters MAA, Gemen EFA, Verstegen RHJ, Wever PC, de Vries E. Both normal memory counts and decreased naive cells favour intrinsic defect over early senescence of Down syndrome T lymphocytes. Pediatr Res. 2010;67:557-62.
23. Verstegen RHJ, Kusters MAA, Gemen EFA, de Vries E. Down syndrome B-lymphocyte subpopulations, intrinsic defect or decreased T-lymphocyte help. Pediatr Res. 2010;67:563-9.
24. Annerén G, Magnusson CGM, Lilja G, Nordvall SL. Abnormal serum IgG subclass pattern in children with Down's syndrome. Arch Dis Child. 1992;67:628-31.
25. Loh RKS, Harth SC, Thong YH, Ferrante A. Immunoglobulin G subclass deficiency and predisposition to infection in Down's syndrome. Pediatr Infect Dis J. 1990;9:547-51. (Pubitemid 20260476)
26. van der Sluijs KF, van Elden L, Nijhuis M, Schuurman R, Florquin S, Jansen HM, et al. Toll-like receptor 4 is not involved in host defense against respiratory tract infection with Sendai virus. Immunol Lett. 2003;89:201-6. (Pubitemid 37222447)
27. Wang JP, Kurt-Jones EA, Finberg RW. Innate immunity to respiratory viruses. Cell Microbiol. 2007;9:1641-6. (Pubitemid 46958791)
28. Julkunen I, Sareneva T, Pirhonen J, Ronni T, Melén K, Matikainen S. Molecular pathogenesis of influenza Avirus infection and virusinduced regulation of cytokine gene expression. Cytokine Growth Factor Rev. 2001;12:171-80. (Pubitemid 32588143)
29. Le Goffic R, Pothlichet J, Vitour D, Fujita T, Meurs E, Chignard M, et al. Cutting edge: influenza Avirus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. J Immunol. 2007;178:3368-72. (Pubitemid 46417600)
30. Hussell T, Pennycook A, Openshaw PJ. Inhibition of tumor necrosis factor reduces the severity of virus-specific lung immunopathology. Eur J Immunol. 2001;31:2566-73. (Pubitemid 32898723)
31. Sun K, Torres L, Metzger DW. A detrimental effect of interleukin- 10 protective pulmonary humoral immunity during primary influenza A virus infection. J Virol. 2010;84:5007-14.
32. Rouse BT, Sehrawat S. Immunity and immunopathology to viruses; what decides the outcome? Nat Rev Immunol. 2010;10:514-26.
33. Lee SMY, Gardy JL, Cheung CY, Cheung TKW, Hui KPY, Ip NY, et al. Systems-level comparison of host-responses elicited by avian H5N1 and seasonal H1N1 influenza viruses in primary human macrophages. PLoS One. 2009;4:e8072.
34. Lee N, Wong CK, Chan PKS, Lun SWM, Lui G, Wong B, et al. Hypercytokinemia and hyperactivation of phospho-p38 mitogenactivated protein kinase in severe human influenza A virus infection. Clin Infect Dis. 2007;45:723-31. (Pubitemid 47378886)
35. Maroun LE. Interferon action and chromosome 21 trisomy (Down syndrome): 15 years later. J Theor Biol. 1996;181:41-6. (Pubitemid 26273550)
36. Epstein LB, Lee SHS, Epstein CJ. Enhanced sensitivity of trisomy 21 monocytes to the maturation-inhibiting effect of interferon. Cell Immunol. 1980;50:191-4. (Pubitemid 10164232)
37. Iwamoto T, Yamada A, Yuasa K, Fukumoto E, Nakamura T, Fujiwara T, et al. Influences of interferon-gamma on cell proliferation and interleukin-6 production in Down syndrome derived fibroblasts. Arch Oral Biol. 2009;54:963-9.
38. Torre D, Broggini M, Zeroli C, Agrifoglio L, Botta V, Casalone R, et al. Serum levels of gamma interferon in patients with Down's syndrome. Infection. 1995;23:66-7.